Investor Relations

Corporate Overview

Pioneering a restorative, off-the-shelf solution for durable cartilage regeneration

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing innovative tissue repair solutions that restore health and enhance quality of life. With an initial focus on orthopedic treatments, Regentis' Gelrin platform technology, based on synchronized, degradable hydrogel implants, regenerates damaged or diseased tissue including inflamed cartilage and bone.

View Events & Presentations

NYSE: RGNT

0.00
Change
0.00 0.00
Volume
0.00
Day
0.00 - 0.00

SEC Filings

Corporate Governance

Email Alerts

Latest Releases

Contact IR

60, Medinat Hyahudim
Entrance C
Herzlia Pituach, Israel 4676652


For general inquiries:
Dr. Ehud Geller +972-9-960-1917
Email: 
ehud@regentis.co.il